New drug trial targets root cause of stubborn blood disorder
Disease control
Not yet recruiting
This study is testing an experimental drug called enatumab for adults with a specific type of autoimmune hemolytic anemia (wAIHA) that has come back or not improved after at least two standard treatments. The drug works by guiding the body's own immune T-cells to attack the abnor…
Phase: PHASE2 • Sponsor: Bing Han • Aim: Disease control
Last updated Mar 23, 2026 15:16 UTC